References
- Buhrer M., Cotonnec J. Y. I., Wermeille M., Bircher J. Treatment of liver disease with malotilate. A pharmacokinetic and pharmacodynamic phase II study in cirrhosis. European Journal of Clinical Pharmacology 1986; 30: 407–416
- Clapp J. W. A new metabolic pathway for a sulfonamide group. Journal of Biological Chemistry 1956; 223: 207–215
- Hansen H. J., Giles W. G., Nadler S. B. Metabolism of 9-ethyl-6-MP-S35 and 9-buthyl-6-MP-S35 in humans. Proceedings of the Society for Experimental Biology and Medicine 1963; 113: 163–165
- Ikeda T., Komai T., Kawai K., Shindo H. Urinary metabolites of 1-(3-Mercapto-2-D-methyl-1-oxopropyl)-L-proline (SQ-14225), a new antihypertensive agent, in rats and dogs. Chemical and Pharmaceutical Bulletin 1981; 29: 1416–1422
- Illing H. P. A., Dutton G. J. Observations on the biosynthesis of thioglucuronides and thioglucosides in vertebrates and molluscs. Biochemical Journal 1970; 120: 16p–17p
- Kaslander J. Formation of an S-giucuronide from tetraethylthiuram disulfide (antabuse) in man. Biochimica et Biophysica Acta 1963; 71: 730–732
- Suzuki H., Ichida F., Takino T., Nagashima H., Hirayama C., Fujisawa K., Furuta S., Monna T., Yamamoto S., Oda T. Therapeutic effects of malotilate of chronic hepatitis and liver cirrhosis: A double-blind, controlled multicenter trial. Excepta Medica 1983; 10: 54–68
- Tanaka H., Kurono H. Derivatives of malonic acid. Japanese Patent 49-26281, 1974, [Chemical Abstracts 81-25646a (1974)]
- Weisiger R. A., Jakoby W. B. Thiol S-methyltransferase from rat liver. Archives of Biochemistry and Biophysics 1979; 196: 631–637
- Yasuhara H., Nonami R., Hakusui H., Sakamoto K. Pharmacokinetics of malotilate in healthy volunteers after oral administration of single and multiple doses. Japanese Journal of Clinical Pharmacology and Therapeutics 1982; 13: 559–572